Patents by Inventor Satoru Todo

Satoru Todo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200079853
    Abstract: The present application relates to generation of regulatory T cells. The present application also relates to uses of the regulatory T cells in treating subjects undergoing organ transplantation. The present application also relates to uses of the regulatory T cells in treating subjects undergoing tissue grafts. Regulatory T cells may be administered to a subject along with one or more antibodies.
    Type: Application
    Filed: November 11, 2019
    Publication date: March 12, 2020
    Inventors: Satoru Todo, Kenichiro Yamashita, Hisashi Bashuda, Ko Okumura
  • Publication number: 20160046715
    Abstract: The present application relates to generation of regulatory T cells, particularly those generated in the presence of anti-CD80 and anti-CD86 antibodies. The present application also relates to uses of the regulatory T cells in treating subjects undergoing organ transplantation. The present application also relates to uses of the regulatory T cells in treating subjects undergoing tissue grafts. Regulatory T cells may be administered to a subject along with one or more antibodies.
    Type: Application
    Filed: May 7, 2014
    Publication date: February 18, 2016
    Inventors: Satoru Todo, Kenichiro Yamashita, Hisashi Bashuda, Ko Okumura
  • Publication number: 20150139971
    Abstract: An object of the present invention is to establish a method that enables safe and convenient large-scale preparation of regulatory dendritic cells. The present invention provides a method for preparing regulatory dendritic cells, which comprises culturing cells that can be induced to result in regulatory dendritic cells in the presence of a [1,2,4]triazolo[1,5-a]pyrimidine derivative.
    Type: Application
    Filed: January 28, 2015
    Publication date: May 21, 2015
    Applicants: NIPPON KAYAKU KABUSHIKI KAISHA, NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY
    Inventors: Satoru TODO, Kenichiro YAMASHITA, Susumu SHIBASAKI
  • Publication number: 20130052734
    Abstract: An object of the present invention is to establish a method that enables safe and convenient large-scale preparation of regulatory dendritic cells. The present invention provides a method for preparing regulatory dendritic cells, which comprises culturing cells that can be induced to result in regulatory dendritic cells in the presence of a [1,2,4]triazolo[1,5-a]pyrimidine derivative.
    Type: Application
    Filed: February 23, 2011
    Publication date: February 28, 2013
    Applicants: National University Corporation Hokkaido University, NIPPON KAYAKU KABUSHIKI KAISHA
    Inventors: Satoru Todo, Kenichiro Yamashita, Susumu Shibasaki
  • Publication number: 20100301203
    Abstract: It is intended to provide a novel diagnosis method for a hepatic disease, in particular, HCC. A serum sugar chain usable as a novel biomarker is provided by analyzing the relationship between the quantitative expression profiles of sugar chains in the serum and individual disease conditions and thus finding a sugar chain showing a change with the progression of a hepatic disease.
    Type: Application
    Filed: November 28, 2008
    Publication date: December 2, 2010
    Inventors: Shin-Ichiro Nishimura, Satoru Todo
  • Patent number: 7098237
    Abstract: A composition for treating or preventing ischemia reperfusion injury which contains an sPLA2 inhibitor as an active ingredient.
    Type: Grant
    Filed: October 7, 1999
    Date of Patent: August 29, 2006
    Assignee: Shionogi & Co., Ltd.
    Inventor: Satoru Todo
  • Patent number: 5348966
    Abstract: Administration of FK506 or related macrolide compounds is effective for the treatment of pyoderma and Sezary's syndrome.
    Type: Grant
    Filed: November 22, 1993
    Date of Patent: September 20, 1994
    Assignee: Fujisawa Pharmaceutical Co., Ltd.
    Inventors: Thomas E. Starzl, Satoru Todo
  • Patent number: 5196437
    Abstract: Macrolide compounds having the structure shown below ##STR1## wherein R.sup.1 is hydroxy or protected hydroxy, R.sup.2 is hydrogen, hydroxy or protected hydroxy, R.sup.3 is methyl, ethyl, propyl or allyl, R.sup.4 is hydroxy, methoxy or oxo, n is 1 or 2 and the symbol of a line and a dotted is a single bond or a double bond, provided that R.sup.2 is not protected hydroxy where R.sup.4 is hydroxy or oxo are used to treat hepatic disease and regenerate liver tissue by facilitating hypertrophy and hyperplasia of hepatocytes.
    Type: Grant
    Filed: December 18, 1990
    Date of Patent: March 23, 1993
    Assignee: Fujisawa Pharmaceutical Company, Ltd.
    Inventors: Thomas E. Starzl, Satoru Todo, Antonio Francavilla